William Carson who is President & Chief Executive Officer, will become Chairman of the Board on Jan. 1, 2020 (news posted on November 14 2019).
Create an alert
to follow the executive moves at Otsuka Pharmaceutical Development & Commercialization.
KKR has acquired J B Chemicals & Pharmaceuticals (posted on Jul 7, 2020).
La Jolla Pharmaceutical has announced the acquisition of Tetraphase Pharmaceuticals (posted on Jun 24, 2020).
Melinta Therapeutics has announced the acquisition of Tetraphase Pharmaceuticals (posted on Jun 5, 2020).
Otsuka Pharmaceutical Development & Commercialization has 2,010 competitors including Johnson & Johnson (United States (USA)), Sanofi (France) and Roche (Switzerland). Otsuka Pharmaceutical Development & Commercialization is owned by Otsuka Pharmaceutical.
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.